Avonne E Connor1, Kate E Dibble2, Stephanie D Boone3, Kathy B Baumgartner3, Richard N Baumgartner3. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. Electronic address: aconnor8@jhu.edu. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 3. Department of Epidemiology and Population Health and the James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Abstract
INTRODUCTION: Soluble tumor necrosis factor receptor-II (sTNF-R2), a pro-inflammatory biomarker, is associated with obesity and breast cancer (BC). The association between sTNF-R2 and risk of mortality after BC has not been studied, specifically among Hispanic women, an at-risk population due to their high prevalence of obesity and poor prognosis. We examined the association between sTNF-R2 and mortality among Hispanic and non-Hispanic white (NHW) BC survivors. METHODS: A total of 397 invasive BC survivors (96 Hispanic, 301 NHW) contributed baseline interview data and blood samples. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using Cox proportional hazards regression models adjusting for clinical factors including body mass index. RESULTS: After a median follow-up time of 13 years, 133 deaths occurred. The association between high vs low levels of plasma sTNF-R2 and mortality was not statistically significant overall (HR, 1.32; 95% CI 0.89-1.98). However, when stratified the mortality risk among Hispanic women was nearly 3-fold (HR, 2.83; 95% CI 1.21-6.63), while risk among NHW women was attenuated (HR, 0.99; 95% CI 0.61-1.61) (p-interaction=0.10). CONCLUSION: Our results suggest Hispanic BC survivors with high sTNF-R2 levels may have increased risk of mortality and could inform targeted interventions to reduce inflammation and improve outcomes.
INTRODUCTION: Soluble tumor necrosis factor receptor-II (sTNF-R2), a pro-inflammatory biomarker, is associated with obesity and breast cancer (BC). The association between sTNF-R2 and risk of mortality after BC has not been studied, specifically among Hispanic women, an at-risk population due to their high prevalence of obesity and poor prognosis. We examined the association between sTNF-R2 and mortality among Hispanic and non-Hispanic white (NHW) BC survivors. METHODS: A total of 397 invasive BC survivors (96 Hispanic, 301 NHW) contributed baseline interview data and blood samples. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using Cox proportional hazards regression models adjusting for clinical factors including body mass index. RESULTS: After a median follow-up time of 13 years, 133 deaths occurred. The association between high vs low levels of plasma sTNF-R2 and mortality was not statistically significant overall (HR, 1.32; 95% CI 0.89-1.98). However, when stratified the mortality risk among Hispanic women was nearly 3-fold (HR, 2.83; 95% CI 1.21-6.63), while risk among NHW women was attenuated (HR, 0.99; 95% CI 0.61-1.61) (p-interaction=0.10). CONCLUSION: Our results suggest Hispanic BC survivors with high sTNF-R2 levels may have increased risk of mortality and could inform targeted interventions to reduce inflammation and improve outcomes.
Authors: Tinuke O Olagunju; Yihang Liu; Li-Jung Liang; James M Stomber; Jennifer J Griggs; Patricia A Ganz; Amardeep Thind; Rose C Maly Journal: Cancer Date: 2018-04-06 Impact factor: 6.860
Authors: S D Boone; K B Baumgartner; N E Joste; C M Pinkston; D Yang; R N Baumgartner Journal: Cancer Causes Control Date: 2013-12-14 Impact factor: 2.506
Authors: K B Baumgartner; W C Hunt; R N Baumgartner; D D Crumley; F D Gilliland; A McTiernan; L Bernstein; R Ballard-Barbash Journal: Am J Epidemiol Date: 2004-12-01 Impact factor: 4.897
Authors: Brandon L Pierce; Rachel Ballard-Barbash; Leslie Bernstein; Richard N Baumgartner; Marian L Neuhouser; Mark H Wener; Kathy B Baumgartner; Frank D Gilliland; Bess E Sorensen; Anne McTiernan; Cornelia M Ulrich Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: Avonne E Connor; Kala Visvanathan; Stephanie D Boone; Nader Rifai; Kathy B Baumgartner; Richard N Baumgartner Journal: NPJ Breast Cancer Date: 2019-01-07